These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Schmidt MK; Meurer L; Volkweis BS; Edelweiss MI; Schirmer CC; Kruel CD; Gurski RR Dis Esophagus; 2007; 20(3):212-6. PubMed ID: 17509117 [TBL] [Abstract][Full Text] [Related]
9. Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma. Segat D; Cassaro M; Dazzo E; Cavallini L; Romualdi C; Salvador R; Vitale MP; Vitiello L; Fassan M; Rugge M; Zaninotto G; Ancona E; Baroni MD Histol Histopathol; 2010 May; 25(5):551-60. PubMed ID: 20238294 [TBL] [Abstract][Full Text] [Related]
10. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus. Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746 [TBL] [Abstract][Full Text] [Related]
11. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140 [TBL] [Abstract][Full Text] [Related]
12. A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus. Clements DM; Oleesky DA; Smith SC; Wheatley H; Hullin DA; Havard TJ; Bowrey DJ J Clin Pathol; 2005 May; 58(5):490-2. PubMed ID: 15858119 [TBL] [Abstract][Full Text] [Related]
13. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus. Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Jankowski J; Hopwood D; Pringle R; Wormsley KG Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848 [TBL] [Abstract][Full Text] [Related]
16. Gastric metaplasia of the proximal esophagus associated with esophageal adenocarcinoma and Barrett's esophagus: what is the connection? Inlet patch revisited. Malhi-Chowla N; Ringley RK; Wolfsen HC Dig Dis; 2000; 18(3):183-5. PubMed ID: 11279338 [TBL] [Abstract][Full Text] [Related]
17. Pilot translational study of dietary vitamin C supplementation in Barrett's esophagus. Babar M; Abdel-Latif MM; Ravi N; Murphy A; Byrne PJ; Kelleher D; Reynolds JV Dis Esophagus; 2010 Apr; 23(3):271-6. PubMed ID: 19930402 [TBL] [Abstract][Full Text] [Related]
18. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
19. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma. Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440 [TBL] [Abstract][Full Text] [Related]
20. Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagus. Going JJ; Fletcher-Monaghan AJ; Neilson L; Wisman BA; van der Zee A; Stuart RC; Keith WN Neoplasia; 2004; 6(1):85-92. PubMed ID: 15068673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]